Natasha S. Anstee

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome

N. Potter, N. Russell, A. Wei, 2022, Blood.

Iron regulatory protein (IRP)–mediated iron homeostasis is critical for neutrophil development and differentiation in the bone marrow

B. Galy, S. Altamura, M. Polycarpou-Schwarz, 2022, bioRxiv.

Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

P. Marlton, A. Roberts, A. Wei, 2023, Blood.

Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia

E. Thompson, A. Roberts, Ensar Halilovic, 2022, Blood.

Intact TP53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

A. Strasser, A. Roberts, A. Wei, 2021, Blood.

ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial

M. Konopleva, K. Patel, D. Kipp, 2022, Blood.